PSDLF Stock UPDATES Prism Med Ltd (PSDLF) 7.3059 09/11/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Prism Med Ltd (PSDLF) 7.3059 $PSDLF

Global Patient Handling Equipment (Wheelchair, Scooter, Beds, Bathroom Safety, Mechanical, Ambulatory) Market Forecasts and Opportunities, 2019
M2 - Thu Sep 11, 5:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zpbnpk/patient_handling) has announced the addition of the "Patient Handling Equipment Market by Product, Type of Care , Accessories & by End User - Global Forecast to 2019" report to their offering. The overall patient handling equipment market will be valued at $8.55 billion in 2014 The global patient handling equipment market exhibits a lucrative growth potential for the next five years. The growth of this market is propelled by the rise in geriatric population and the increase in lifestyle diseases such as diabetes and Cardiovascular Diseases (CVD) leading to increased disabilities. The market is further driven by factors such as government policies promoting the use of patient handling equipment, technological advancement, injuries incurred during patient handling which are very costly to recover. Advancement in technology and development of new products has contributed largely to patient handling equipment market to growth The medical beds segment will have the largest share of the total patient handling equipment market in 2014 and will continue to grow with a healthy CAGR in the forecast period. The high growth of this segment is attributed to the growing demand for the equipment for the expanding geriatric population, mounting prevalence of lifestyle diseases and technological advancements. Evolution in technology have made the equipment more user's friendly and portable. The non-mechanical equipment on the other hand will be the fastest growing segment in the coming years. It will account for very less share in the market in 2014, but gradually their acceptance as well as popularity will lead to higher market share. The home care segment is expected to grow at the highest growth rate in the forecast period. The delivery of health care services in home is more cost efficient than the hospital and in other care institutions on long term basis. Furthermore, favourable reimbursement policies and government support will contribute to the market growth. Getinge Group was the clear market leader in patient handling equipment market in 2014. Getinge Group also enjoys a high level of brand loyalty amongst customers due to its large product portfolio, good quality products, and an efficient after-sales service. Hill-Rom distantly followed Getinge Group and thus became the second leading company in the patient handling equipment market in 2014. Styker will be the third leading company in 2014 in patient handling equipment market. Report Scope By Product - Wheelchair and scooters - Manual wheelchair - Powered Wheelchair - Scooters - Medical Beds - Curative care beds - Psychiatric care beds - Long term care beds - Others - Bathroom safety supplies - Mechanical equipment - Non mechanical equipment - Ambulatory Aids - Others By Accessories - Lifting accessories - Transfer accessories - Evacuation accessories - Stretcher accessories - Hospital Bed Accessories - Others (Bariatric boards, transfer sheets) By End User - Home care - Hospital - Elderly care - Others (Nursing homes, long term care) By Type of Care - Bariatric care - Fall prevention - Critical care - Wound care - Others (transfers) Companies Mentioned - Getinge Group (Arjohuntleigh) - Guldmann Inc. - Handicare - Hill-Rom Holdings, Inc. - Invacare Corporation. - Joerns Healthcare - Linet Spol. S.R.O. - Prism Medical - Stiegelmeyer & Co. GMBH - Stryker Corporation For more information visit http://www.researchandmarkets.com/research/zp...t_handling

Prism Medical Announces Substantial Issuer Bid
Marketwire - Fri Aug 08, 5:24AM CDT
PRISM MEDICAL LTD. (TSX VENTURE: PM) ("Prism" today announced that its board of directors (the "Board of Directors" has authorized an offer to repurchase for cancellation up to $35 million worth of its common shares ("Shares" , at a price range of $8.00 to $8.75 per Share, through a Dutch auction type substantial issuer bid (the "Offer" . Up to a maximum of 4,375,000 Shares may be repurchased under the issuer bid, representing approximately 49% of Prism's outstanding Shares. Prism currently has approximately 8,897,779 Shares issued and outstanding. All monetary references in this news release are in Canadian dollars.

Prism Medical Reports Officer Appointment
Marketwire - Thu Jul 31, 10:04AM CDT
Prism Medical Ltd., ("Prism Medical" or "the Company" (TSX VENTURE: PM), a leading provider of durable medical equipment and related services to the mobility challenged, today reported changes to its senior officer appointments. As part of the Company's restructuring plan, George Chiarucci, Chief Financial Officer, will be leaving the Company at the end July. He will be available to the Company in a consultative capacity.

Prism Medical Reports Second Quarter Results
Marketwire - Mon Jul 28, 5:17PM CDT
Prism Medical Ltd., ("Prism Medical" or "the Company" (TSX VENTURE: PM), a leading provider of durable medical equipment and related services to the mobility challenged, today reported financial results for the second quarter (Q2) ended May 31, 2014.

Prism Medical Reports Fourth Quarter and Fiscal 2013 Results
Marketwire - Tue Mar 25, 4:52PM CDT
Prism Medical Ltd. ("Prism Medical" or "the Company" (TSX VENTURE: PM), a leading provider of durable medical equipment and related services to the mobility challenged, today reported financial results for the fourth quarter (Q4) and fiscal year ended November 30, 2013.

Prism Medical Acquires 100% of MedCare Products Inc.
Marketwire - Mon Feb 10, 8:04AM CST
Prism Medical Ltd., ("Prism Medical" or "the Company" (TSX VENTURE: PM), a leading provider of durable medical equipment and related services to the mobility challenged, today announced that it has acquired an additional 51% ownership interest in MedCare Products Inc. (MedCare), resulting in MedCare becoming a 100% owned subsidiary.

Prism Medical Ltd. Declares Dividend
Marketwire - Tue Jan 28, 8:06AM CST
Prism Medical Ltd. ("Prism Medical" or the "Company" (TSX VENTURE: PM), a leading provider of durable medical equipment and related services to the mobility challenged announced today that its Board of Directors has approved a dividend of $0.08 per common share payable on March 3, 2014 to the shareholders of record on February 21, 2014.

Prism Medical Announces Change in Senior Management Roles
Marketwire - Thu Jan 23, 3:02PM CST
Prism Medical Ltd., ("Prism Medical" or "the Company" (TSX VENTURE: PM), a leading provider of durable medical equipment and related services to the mobility challenged, today announced a change in senior management roles. Prism Medical UK has developed well over the last few years and is now in a position where there are significant opportunities to grow the business and maximize shareholder value. As result Stuart Meldrum has agreed to again lead the UK team as its CEO in an effort to maximize these opportunities. Andy McIntyre will assume the CEO responsibilities in addition to his current responsibilities as Executive Chairman.

Prism Medical Ltd. Stock Option Amendments
Marketwire - Thu Aug 08, 8:01AM CDT
Prism Medical Ltd. ("Prism Medical" or the "Company" (TSX VENTURE: PM), a leading provider of durable medical equipment and related services to the mobility challenged, announced today that it has been granted conditional approval from the TSX Venture Exchange Inc. to amend certain stock option agreements affecting options to acquire 247,000 common shares at prices ranging from $4.72 to $5.20, by extending the expiry dates to May 31, 2014. The reason for the amendment is that the Company's stock option plan does not allow for automatic extensions of the "expiry date" of options if the expiry date occurs during a "blackout" period pursuant to the Company's securities trading policy. As a result the optionees may not be able to exercise outstanding options. The Company intends to present an amendment to the stock option plan addressing this issue for approval by the shareholders at the next annual meeting to be held prior to the end of May, 2014.

PM, MDW Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Tue Jul 09, 7:22AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Prism Medical Ltd (NYSE M), Midway Gold Corp (AMEX:MDW) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

PM, MDW, IPCM, PBP Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Jun 07, 6:08AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Prism Medical Ltd (NYSE M), Midway Gold Corp (AMEX:MDW), IPC The Hospitalist Co Inc (NASDAQ:IPCM), PowerShares S&P 500 BuyWrite Portfolio (NYSE BP) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

Prism Medical Reports First Quarter Results
Marketwire - Mon Apr 29, 3:16PM CDT
Prism Medical Ltd., ("Prism Medical" or "the Company" (TSX VENTURE: PM), a leading provider of durable medical equipment and related services to the mobility challenged, today reported financial results for the first quarter (Q1) ended February 28, 2013.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Ameripath USA Collaborates with Recovery Resolutions to Support Recovery Housing

Updated Category News Views 308

Ameripath USA's New Partnership for Recovery Housing Ameripath USA has formed a strategic partnership with Recovery Resolutions LLC to significantly improve access to high-quality Addiction Recovery Homes throughout the country. This collaboration merges Ameripath's extensive real estate expertise with Recovery Resolutions' impressive success model, boasting a 95% success...

Continue Reading
Finzly’s ISO 20022 Migration Readiness Sets Industry Standards

Updated Category News Views 311

Finzly’s Innovations in ISO 20022 Payment Standards Finzly is at the forefront of transforming how financial institutions manage payments through its state-of-the-art platform designed for modern banking needs. As the shift to SWIFT MX ISO 20022 continues, Finzly's clientele is emerging as early adopters, demonstrating a commitment to embracing new technologies that...

Continue Reading
Innovative Drug Delivery Solutions for Parkinson's Disease

Updated Category News Views 251

Serina Therapeutics' Approach to Parkinson's Disease Serina Therapeutics is at the forefront of developing new treatments for complex neurological disorders, particularly Parkinson’s disease. This progressive neurological disorder significantly impacts motor functions and quality of life for those affected. With innovative solutions on the horizon, Serina is prepared to...

Continue Reading
Waters Corporation Leader to Speak at HealthCONx Conference

Updated Category News Views 124

Waters Corporation to Participate in HealthCONx Conference Waters Corporation (NYSE: WAT), located in Milford, Massachusetts, is pleased to announce its participation in the upcoming HealthCONx Conference. Udit Batra, the President and Chief Executive Officer of Waters, will engage in an insightful fireside chat set for Wednesday, December 4th, 2024, at 10:00 AM Eastern...

Continue Reading
mRNA Synthesis and Manufacturing Market Expected to Grow Steadily

Updated Category News Views 33

Growing Insights into the mRNA Synthesis and Manufacturing Market The mRNA synthesis and manufacturing market is on a promising trajectory, with projections indicating substantial growth from USD 624.4 million to USD 738.3 million by 2029. This expansion translates into a compound annual growth rate (CAGR) of 3.4%. Several factors are propelling this growth, including an...

Continue Reading